Myrbetriq (mirabegron) is a prescription medication used to treat overactive bladder, or OAB. It targets the three hallmark symptoms of the condition: the sudden, hard-to-control urge to urinate, urinating too frequently throughout the day, and urge urinary incontinence (leaking urine when the urge strikes). It can be prescribed on its own or in combination with another type of bladder medication called an antimuscarinic.
How Overactive Bladder Feels
Overactive bladder isn’t just “going to the bathroom a lot.” It’s a pattern of symptoms that revolves around urgency, the sudden and intense need to urinate that’s difficult to delay. Most people with OAB urinate eight or more times in 24 hours, and many wake up two or more times per night. Some also experience leakage on the way to the bathroom, which is the incontinence component.
These symptoms can overlap with other conditions like urinary tract infections or prostate enlargement, so a diagnosis of OAB typically means those other causes have been ruled out. Myrbetriq is specifically designed for the urgency-driven pattern, not for stress incontinence (leaking when you cough, sneeze, or exercise), which has a different underlying cause.
How Myrbetriq Works
Your bladder wall contains a thick layer of muscle called the detrusor. During normal filling, this muscle stays relaxed so the bladder can expand. In overactive bladder, the detrusor contracts involuntarily during the filling phase, creating that sudden sense of urgency even when the bladder isn’t full.
Myrbetriq activates a specific receptor (the beta-3 adrenergic receptor) on the detrusor muscle, which signals it to relax. This allows the bladder to hold more urine comfortably during the storage phase, reducing the frequency and urgency of bathroom trips. It’s a fundamentally different approach from the older class of OAB drugs, which work by blocking a different set of nerve signals to the bladder.
How Well It Works
In clinical trials, people taking Myrbetriq at the standard 50 mg dose averaged about 2.5 fewer bathroom trips per day after 12 weeks. For those with incontinence, leakage episodes dropped by roughly one fewer episode per day compared to baseline. Those numbers may sound modest, but for someone going 12 or 14 times a day, cutting two to three trips makes a real difference in daily life, especially overnight.
Results aren’t instant. At the higher dose, most people notice meaningful improvement within about 4 weeks. At the lower starting dose, it can take closer to 8 weeks. This is worth knowing so you don’t give up on the medication too early. Full benefit builds gradually as the drug reaches a steady level in your system.
How It Compares to Older Bladder Medications
Before Myrbetriq came along, the standard treatment for OAB was a class of drugs called anticholinergics (or antimuscarinics). These include medications like oxybutynin, tolterodine, and solifenacin. They work well for many people, but they come with a well-known set of side effects: dry mouth, constipation, and urinary retention. For older adults, there’s also growing concern about their long-term effect on memory and cognitive function, since they block a chemical messenger (acetylcholine) that the brain relies on.
Myrbetriq works through an entirely different pathway, so it largely avoids those particular problems. A large systematic review comparing mirabegron to a range of anticholinergics found it was equally effective at relieving OAB symptoms but significantly better tolerated. Specifically, it caused less dry mouth than 21 out of 22 anticholinergic comparators, less constipation than 9 out of 20, and less urinary retention than 7 out of 10. For people who tried an anticholinergic and quit because of side effects, Myrbetriq is often the next step.
In some cases, Myrbetriq is prescribed alongside an anticholinergic (solifenacin specifically) for people who haven’t gotten enough relief from either drug alone. This combination therapy is FDA-approved and can provide additional symptom control, though it does mean living with some degree of anticholinergic side effects.
Common Side Effects
Myrbetriq has its own side effect profile, distinct from the anticholinergics. The most commonly reported issues include headache, dizziness, urinary tract symptoms (painful urination, bladder discomfort), and changes in heart rate. Some people notice a slightly faster or irregular heartbeat.
Blood pressure increases are a known concern. Myrbetriq can raise blood pressure modestly because the beta-3 receptor it targets also plays a role in cardiovascular function. If you already have high blood pressure, your provider will likely want to monitor your readings more closely after starting the medication. Blurred vision and nasal congestion have also been reported, though less frequently.
Most side effects are mild and tend to settle over the first few weeks. The absence of dry mouth and constipation is the main reason many people find Myrbetriq easier to stick with long-term compared to older options.
What to Expect When Starting
Myrbetriq comes as an extended-release tablet taken once daily, with or without food. The tablet should be swallowed whole rather than crushed or chewed, since the extended-release coating controls how the drug is absorbed throughout the day. Most people start at a lower dose, with the option to increase after a few weeks if symptoms haven’t improved enough.
Because the medication takes several weeks to reach its full effect, it’s typically evaluated after at least 8 weeks before deciding whether it’s working. During that time, many providers suggest keeping a bladder diary, tracking how often you urinate and any leakage episodes, so you have an objective measure of improvement rather than relying on memory alone.
People with significant kidney or liver problems may need a lower maximum dose, since the drug is processed through both organs. Your provider will factor this in when prescribing.
Who Myrbetriq Is Best Suited For
Myrbetriq is a good fit for adults with urgency-predominant overactive bladder, particularly those who have tried anticholinergics and found the side effects intolerable, or those who want to avoid anticholinergic effects from the start. It’s also commonly considered for older adults, where the cognitive risks of anticholinergics are a bigger concern.
It’s not appropriate for people with uncontrolled high blood pressure, and it’s not designed for bladder problems caused by obstruction (like an enlarged prostate blocking urine flow) or for stress incontinence. If your main issue is leaking during physical activity rather than a sudden overwhelming urge, Myrbetriq is unlikely to help.